NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital …
Noom, the leading digital healthcare company helping people live better, longer lives, today announced its second book with the release of its first-ever official cookbook, The Noom Kitchen.
We are delighted to announce winners of the European Patient Digital Health Awards.…
WellRight, a corporate wellness leader delivering customizable and complete wellbeing programs, announced two new members of its leadership team: Joy Wilson as head of product, and Meghan McGraw as senior director, consultant relations.
Alerje, Inc. announces it has been selected by AFWERX for a SBIR Phase I focused on focusing on a Rapid Naloxone Deployment System (RNDS) to address some of the most pressing challenges in the Department of the Air Force (DAF) and beyond in our country.
mPulse, a leader in conversational AI and digital engagement solutions for the healthcare industry, today announced the acquisition of HealthTrio and Decision Point Healthcare Solutions, marking a significant milestone in the company's growth and commitment to enhancing the healthcare consumer experience.
Verato, the identity experts for healthcare, today announced that it has earned certified status by HITRUST for information security. After undergoing a rigorous review process and demonstrating the ability to meet high data-protection standards, Verato’s hMDM platform this has been awarded HITRUST Risk-based, 2-year certification.
Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Mendaera, a Silicon Valley-based company developing technology to help healthcare providers more easily and confidently perform procedures through the power of medical robotics, today announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip™ technology.
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that it has received authorization from the U.S. Food and Drug Administration (FDA) to expand the label for EndeavorRx® from 8 to 12 year-old patients with primarily inattentive or combined-type ADHD who have a demonstrated attention issue to include older children aged 13 - 17.
HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced significant developments for the use of artificial intelligence (AI) applied to its proprietary vectorelectrocardiography (VECG) technology, including the addition of new leadership and advisory roles.